Stock Groups

Amgen Earnings, Revenue Beat in Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Amgen Earnings, Revenue Beat in Q3

Amgen (NASDAQ 🙂 announced Tuesday that the third quarter beat analyst forecasts with revenue surpassing expectations.

Amgen posted earnings per share (EPS) of $4.67 on $6.71B in revenue. Investing.com polled analysts and predicted an EPS of 4.27 for $6.67B in revenue.

Amgen shares have fallen 6% since the start of the year. However, they are still 22.53% below their 52-week high of $276.69 on January 28. These shares are outperforming Nasdaq, which has risen 21.43% since the beginning of the year.

Amgen is following other top Healthcare industry earnings this month

Amgen’s report follows an earnings beat by Merck&Co on Thursday, who reported EPS of $1.75 on revenue of $13.15B, compared to forecasts EPS of $1.55 on revenue of $12.32B.

Hoya Corp beat all expectations with a third quarter EPS at $1.03 on $1.43B in revenue, as compared to EPS forecasted for $0.9742 on $1.42B revenue.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]